Readiness, not diagnosis

Evidence Note

What is the question?

Does the evidence support organising adult gender-affirming care around an assessment of readiness — decision-making capacity, informed understanding, and psychosocial stability — rather than around confirming a diagnostic label? And where the two diverge in practice, is there direct evidence that one produces better outcomes, or is the case for readiness largely indirect? This note is about adults; the questions for children and adolescents are different, and are not addressed here.

What does the evidence say?

The clearest finding is directional. Across successive revisions of the main international standards, and in a systematic review of how readiness has been assessed over time, the field has moved away from a narrow focus on diagnosing and toward informed decision-making, autonomy, and flexibility. The vocabulary of “readiness” is not new — the standards long distinguished objective eligibility from a clinician’s judgement of preparedness — but it is now being asked to carry the weight the diagnosis once carried.

The diagnostic label has itself shifted. The World Health Organization moved gender incongruence out of its mental-disorders chapter while keeping a diagnostic category so that access to care is preserved. A diagnosis, in this sense, now functions less as a marker of illness and more as an administrative key.

The readiness-centred alternative has been both articulated and put into practice. It has been set out explicitly as an alternative to requiring a dysphoria diagnosis, and clinics have built criteria around informed consent, capacity, and stability rather than around the diagnosis. Where this has been measured, the great majority of adults attending an informed-consent service were assessed as able to consent to hormone therapy with their primary-care clinician, and satisfaction was high. A comparison of clinic populations under the two models exists, but it is descriptive — it does not show that either model produces better health outcomes.

How strong is the evidence?

It is mixed, and the mix is the point. The evidence that the field is moving toward readiness, and that readiness-centred care is feasible and well-received, is convergent but mostly indirect and observational — single clinics, single health systems, satisfaction and feasibility rather than long-term outcomes. There is no trial, and no prospective comparison, isolating the effect of organising care around readiness versus a label. So the directional and feasibility claim is reasonably supported; the stronger claim — that readiness-organised care is clinically superior — is not yet demonstrated. The single best-evidenced, most actionable element is the feasibility one: in practice, most adults can give informed consent to hormone therapy in a primary-care setting, with mental-health input reserved for those who need it.

Where are the uncertainties?

Two figures often imported into this debate — low surgical regret, and the wellbeing benefits of hormones — describe the effects of treatments, not the model of access, so they cannot settle the readiness question without over-reach. The access-model studies that do exist are observational, so differences may reflect who chooses which clinic as much as the model itself. And the deepest caution is conceptual: readiness can quietly become a new gate. If capacity is assessed with the same underlying suspicion, the door has simply been relabelled.

Readiness, asked well, is still an assessment. It simply stops requiring proof of pain.

That is the line separating a genuine shift from a cosmetic one.

What does this mean for practice?

Although certainty is incomplete, a number of practical conclusions can still be drawn.

The clearest and lowest-risk is that decision-making capacity is the appropriate centre of an adult assessment, and that most adults have it — so an assessment can be built to establish understanding and consent rather than to extract proof of distress. This is the element with the firmest evidence behind it.

A second, held more tentatively because the comparative evidence is thinner, is that moving the focus from label to readiness appears feasible and is well-received, and may ease the bottleneck that diagnostic gatekeeping creates — though without the outcome data to promise it improves results.

What the evidence does not support is replacing one reflexive gate with another. Readiness is worth adopting as a change in what is assessed, and how it is delivered — not as a slogan for assessing nothing, and not, on current evidence, as a claim of proven superiority.